{"id":88,"date":"2019-12-04T17:30:49","date_gmt":"2019-12-04T17:30:49","guid":{"rendered":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/chapter\/module-2-key-terms\/"},"modified":"2020-12-07T16:51:30","modified_gmt":"2020-12-07T16:51:30","slug":"module-2-key-terms","status":"publish","type":"chapter","link":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/chapter\/module-2-key-terms\/","title":{"rendered":"Ch. 3.4: Key Terms"},"content":{"raw":"

bio-psycho-soci<\/strong>al-spiritual<\/strong>:<\/strong> a perspective commonly applied in the substance use arena recognizing the interacting and integrative influences of biological, psychological, social\/physical environment, and spiritual context.<\/p>\r\n

DEA<\/strong>: <\/strong>The U.S. Drug Enforcement Agency, setting policy regarding the status of controlled substances.<\/p>\r\n

DSM-5<\/strong>:<\/strong> The American Psychiatric Association\u2019s Diagnostic and Statistical Manual of Mental Disorders (version 5) used in the diagnosis of substance use disorder and many other mental\/psychiatric conditions; widely used across the U.S. and some other nations.<\/p>\r\n

harm reduction<\/strong>:<\/strong> An approach to intervention (treatment or policy) where the short-term goal is to reduce potential for harmful outcomes resulting from substance misuse, <\/span>whether or not<\/span> the substance misuse is eliminated or reduced [note this does not mean that there is not also a long-term goal of reducing or eliminating the substance misuse, as well].<\/span><\/p>\r\n

ICD-11:<\/strong> The World Health Organization\u2019s International Classification of Diseases and Related Health Conditions used in the diagnosis of substance use disorder and many other physical and mental\/psychiatric conditions; widely used in other nations.<\/p>\r\n

recovery orientation<\/strong>:<\/strong> An holistic approach to supporting the \u201cwhole\u201d person in recovering from substance use disorder that integrates professional, paraprofessional, and natural\/indigenous helpers in the process and addresses all aspects of wellness promotion [note that this often includes advocacy efforts].<\/p>\r\n

Schedule I-Schedule V drugs:<\/strong> Classification categories for controlled substances established by the U.S. DEA; Schedule I is the most highly controlled class, having the greatest potential for abuse and no recognized medical use in the U.S., and Schedule V is the least controlled class of substances that remain controlled substances (as compared to over-the-counter\/OTC products).<\/p>\r\n

s<\/strong>ubstance misuse<\/strong>:<\/strong> Use of psychoactive substances in risky patterns or risky situations.<\/p>\r\n

substance use<\/strong>:<\/strong> Introduction of psychoactive substances into the body.<\/p>\r\n

substance use disorder<\/strong>:<\/strong> A diagnosable condition, meeting specific criteria, distinguished by degree of severity (number of criteria met) and type(s) of substances involved; discrete from other mental\/psychiatric\/behavioral health conditions in that the symptoms are influenced by substance use\/misuse, and discrete from substance withdrawal syndrome.<\/p>\r\n

t<\/strong>olerance<\/strong>:<\/strong> With repeated use, requiring higher doses of a substance (or type of substance) to achieve the same effects or experiencing lesser effects (even withdrawal) when the same dose is used [note that this describes acquired tolerance; base tolerance refers to the amounts initially needed to achieve the same effects experienced by others].<\/p>\r\n

w<\/strong>ithdrawal<\/strong>:<\/strong> Following repeated use of a substance (or type of substance), the body adapts to the presence of the substance such that a person experiences physical and\/or psychological effects\/symptoms when the substance use stops or markedly decreases [note that withdrawal occurs to a greater extent with some types of substances than others and that unmonitored withdrawal from some substances can be deadly].<\/p>","rendered":"

bio-psycho-soci<\/strong>al-spiritual<\/strong>:<\/strong> a perspective commonly applied in the substance use arena recognizing the interacting and integrative influences of biological, psychological, social\/physical environment, and spiritual context.<\/p>\n

DEA<\/strong>: <\/strong>The U.S. Drug Enforcement Agency, setting policy regarding the status of controlled substances.<\/p>\n

DSM-5<\/strong>:<\/strong> The American Psychiatric Association\u2019s Diagnostic and Statistical Manual of Mental Disorders (version 5) used in the diagnosis of substance use disorder and many other mental\/psychiatric conditions; widely used across the U.S. and some other nations.<\/p>\n

harm reduction<\/strong>:<\/strong> An approach to intervention (treatment or policy) where the short-term goal is to reduce potential for harmful outcomes resulting from substance misuse, <\/span>whether or not<\/span> the substance misuse is eliminated or reduced [note this does not mean that there is not also a long-term goal of reducing or eliminating the substance misuse, as well].<\/span><\/p>\n

ICD-11:<\/strong> The World Health Organization\u2019s International Classification of Diseases and Related Health Conditions used in the diagnosis of substance use disorder and many other physical and mental\/psychiatric conditions; widely used in other nations.<\/p>\n

recovery orientation<\/strong>:<\/strong> An holistic approach to supporting the \u201cwhole\u201d person in recovering from substance use disorder that integrates professional, paraprofessional, and natural\/indigenous helpers in the process and addresses all aspects of wellness promotion [note that this often includes advocacy efforts].<\/p>\n

Schedule I-Schedule V drugs:<\/strong> Classification categories for controlled substances established by the U.S. DEA; Schedule I is the most highly controlled class, having the greatest potential for abuse and no recognized medical use in the U.S., and Schedule V is the least controlled class of substances that remain controlled substances (as compared to over-the-counter\/OTC products).<\/p>\n

s<\/strong>ubstance misuse<\/strong>:<\/strong> Use of psychoactive substances in risky patterns or risky situations.<\/p>\n

substance use<\/strong>:<\/strong> Introduction of psychoactive substances into the body.<\/p>\n

substance use disorder<\/strong>:<\/strong> A diagnosable condition, meeting specific criteria, distinguished by degree of severity (number of criteria met) and type(s) of substances involved; discrete from other mental\/psychiatric\/behavioral health conditions in that the symptoms are influenced by substance use\/misuse, and discrete from substance withdrawal syndrome.<\/p>\n

t<\/strong>olerance<\/strong>:<\/strong> With repeated use, requiring higher doses of a substance (or type of substance) to achieve the same effects or experiencing lesser effects (even withdrawal) when the same dose is used [note that this describes acquired tolerance; base tolerance refers to the amounts initially needed to achieve the same effects experienced by others].<\/p>\n

w<\/strong>ithdrawal<\/strong>:<\/strong> Following repeated use of a substance (or type of substance), the body adapts to the presence of the substance such that a person experiences physical and\/or psychological effects\/symptoms when the substance use stops or markedly decreases [note that withdrawal occurs to a greater extent with some types of substances than others and that unmonitored withdrawal from some substances can be deadly].<\/p>\n","protected":false},"author":7,"menu_order":4,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":[],"pb_section_license":""},"chapter-type":[48],"contributor":[],"license":[],"class_list":["post-88","chapter","type-chapter","status-publish","hentry","chapter-type-numberless"],"part":60,"_links":{"self":[{"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/pressbooks\/v2\/chapters\/88","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/wp\/v2\/users\/7"}],"version-history":[{"count":5,"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/pressbooks\/v2\/chapters\/88\/revisions"}],"predecessor-version":[{"id":1011,"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/pressbooks\/v2\/chapters\/88\/revisions\/1011"}],"part":[{"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/pressbooks\/v2\/parts\/60"}],"metadata":[{"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/pressbooks\/v2\/chapters\/88\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/wp\/v2\/media?parent=88"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/pressbooks\/v2\/chapter-type?post=88"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/wp\/v2\/contributor?post=88"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/wp\/v2\/license?post=88"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}